ArticleBreast cancer research : BCR2026
Serum perfluoroalkyl substances (PFASs) concentrations and associations with mammographic density in postmenopausal women.
Article in Breast cancer research : BCR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPerfluoroalkyl substances (PFASs) are possible carcinogens with widespread population exposure. Mammographic density (MD) is a biomarker of breast cancer risk that may offer important insights into potential mechanisms of breast carcinogenesis. Examining associations between PFAS exposure and MD may elucidate pathways by which PFASs could affect breast cancer risk. However, associations between PFAS exposure and MD remain poorly studied. We sought to evaluate associations of individual PFASs and their chemical mixture with percent mammographic density and dense breast area.
methodsWe analyzed data from 186 postmenopausal, cancer-free women not currently using hormone therapy from the Susan G. Komen Tissue Bank. Percent mammographic density (PMD) and dense breast area (DBA) were measured from digital mammography images taken near the time of blood sample donation. Serum PFAS concentrations were measured using online solid-phase extraction followed by high-pressure liquid chromatography with tandem mass spectrometry (HPLC-MS/MS). Associations were examined using multivariable linear regression and Quantile g-computation.
resultsParticipants had a mean age of 58.7 years and mean body mass index of 29.6 kg/m², and most were White (72.6%). The vast majority of mammograms were performed within 2 years of blood sample donation (88%). No statistically significant associations were observed with individual PFASs and either PMD or DBA in analyses adjusted for confounding variables. Quantile G-computation analyses did not identify a statistically significant effect of the PFAS mixture on PMD or DBA. Similar results were observed in analyses stratified by body mass index or breastfeeding history.
conclusionsOverall, our study did not identify strong and significant associations between a panel of major PFASs and MD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.